Αγαπητοί συνάδελφοι, σας ενημερώνουμε για την διεξαγωγή του κοινού συμποσίου της “Μονάδας Μεταμόσχευσης Μυελού των Οστών” του Νοσοκομείου Ελπίδα Ογκολογική Κλινική και του “Sidney Kimmel Comprehensive Cancer Center” του νοσοκομείου Johns Hopkins με θέμα: “Stem Cell Transplantation and Novel Immunotherapies”
Η γλώσσα του συμποσίου είναι τα Αγγλικά και η είσοδος είναι ελεύθερη
Scientific Program
December, 13
10:00-10:30 Opening Words
10:30-11:30
Monoclonal antibodies in pediatric acute leukemias: current knowledge and future prospects
Chair: Sophia Polychronopoulou, Donald Small
– Patrick Brown: Monoclonal antibodies in pediatric acute lymphoblastic leukemia
– Haris Kelaidi: Monoclonal antibodies in pediatric acute myeloid leukemia
11:30-13:00
CAR-T cell therapy for Acute Leukemias
Chair: Evgenios Goussetis, Panagiotis Tsirigotis
– Patrick Brown: CAR-T for ALL
– Challice Bonifant: Generation of CAR-T against AML
– Katerina Kaisari: CAR-T cell manufacturing using a closed system (Prodigy)
13:00-15:00 Lunch Break
15:00-16:00
Haploidentical Transplantation for hematologic malignancies
Chair: Vassiliki Kitra-Roussou, Kostas Gkirkas
– Heather Symons: Haploidentical transplant with post-stem cell infusion high dose Cytoxan
– Eleni-Dikaia Ioannidou: T-cell depleted haploidentical cell transplantation
16:00-17:00
Complications post HSCT
Chair: Ioannis Baltadakis, Ken Cooke
– Keneth Cooke: Pulmonarycomplications post-BMT
– Anna Komitopoulou: Viral complications post HSCT – viral specific T cells
December, 14
10:00-11:00
Molecular Genetics for classification and monitoring of Pediatric ALL
Chair: Ioulia Peristeri, Anna Paisiou
– Mirella Ampatzidou: Pediatric ALL: A genomic perspective
– Katerina Katsibardi – Stavros Glentis: Molecular monitoring of MRD in pediatric ALL
11:00-12:00
Solid tumors
Chair: Margarita Baka, Vassilios Papadakis
– Vassilios Papadakis: Immunotherapy for neuroblastoma
– Marina Servitzoglou: Targeted therapy for pediatric solid tumors other than neuroblastoma
12:00-14:00 Lunch Break
14:00-15:00
Induced Pluripotent Stem Cells (IPSCs)
Chair: Maria Tzetis, Evgenios Goussetis
– Elias Zambidis: Generation of IPSCs for tissue repair
– Irene Sfougataki: IPSCs for modeling of hematological diseases
15:00-16:00
Hemoglobinopathies
Chair: Antonis Kattamis – Vassiliki Kitra-Roussou
– Chris Gamper: Haplo-BMT for sickle cell anemia/ thalassemia
– Christina Oikonomopoulou: Gene therapy-gene editing for thalassemia